Role of angiogenesis-related genes in cleft lip/palate: Review of the literature

International Journal of Pediatric Otorhinolaryngology

Volumn 78, Issue 10, 2014, Pages 1579-1585

  Francois Fiquet C ^a,b,c   Poli Merol, M L ^a   Nguyen, P ^b   Landais, E ^c   Gaillard, D ^c   Doco Fenzy, M ^b,c  

^a AMERICAN MEMORIAL HOSPITAL   (France)

^b Reims University Hospital   (France)

^c HÔPITAL MAISON BLANCHE   (France)

Author keywords

Angiogenesis; Cleft lip; Cleft palate; Etiologic; Gene; Genetic

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; SIGNAL PEPTIDE;

ANGIOGENESIS; APOPTOSIS; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CLEFT LIP; CLEFT PALATE; FGF 9 GENE; FGF8 GENE; FGFR1 GENE; FGFR2 GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INACTIVATION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MESENCHYME CELL; MMP3 GENE; NEURAL CREST; NONHUMAN; PATHOGENESIS; PDGF C GENE; PDGFRA GENE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TGFA GENE; TGFB3 GENE; TIMP2 GENE; VEGF GENE; GENETICS;

CLEFT LIP; CLEFT PALATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84908005865     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2014.08.001     Document Type: Review

References (69)

1. Ardinger H.H., Buetow K.H., Bell G.I., Bardach J., VanDemark D.R., Murray J.C. Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am. J. Hum. Genet. 1989, 45(3):348-353.
2. Shiang R., Lidral A.C., Ardinger H.H., Buetow K.H., Romitti P.A., Munger R.G., et al. Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft palate only (CPO). Am. J. Hum. Genet. 1993, 53(4):836-843.
3. Jugessur A., Lie R.T., Wilcox A.J., Murray J.C., Taylor J.A., Saugstad O.D., et al. Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: a case-parent triad analysis. Genet. Epidemiol. 2003, 24:230-239.
4. Shaw G.M., Wasserman C.R., Lammer E.J., O'Malley C.D., Murray J.C., Basart A.M., et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am. J. Hum. Genet. 1996, 58:551-561.
5. Shaw G.M., Wasserman C.R., Murray J.C., Lammer E.J. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac. J. 1998, 35:366-370.
6. Jugessur A., Lie R.T., Wilcox A.J., Murray J.C., Taylor J.A., Saugstad O.D., et al. Cleft palate, transforming growth factor alpha gene variants, and maternal exposures: Assessing gene-environment interactions in case-parent triads. Genet. Epidemiol. 2003, 25(4):367-374.
7. Zeiger J.S., Beaty T.H., Liang K.Y. Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac. J. 2005, 42:58-63.
8. Sull J.W., Liang K.Y., Hetmanski J.B., Wu T., Fallin M.D., Ingersoll R.G., et al. Evidence that TGFA influences risk to cleft lip with/without cleft palate through unconventional genetic mechanisms. Hum. Genet. 2009, 126:385-394.
9. Miettinen P.J., Chin J.R., Shum L., Slavkin H.C., Shuler C.F., Derynck R., et al. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat. Genet. 1999, 22(1):69-73.
10. Martinelli M., Scapoli L., Pezzetti F., Spinelli G., Lunardi S., Carinci F. Lack of association between common polymorphisms of epidermal growth factor receptors and nonsyndromic cleft lip with or without cleft palate. Int. J. Pediatr. Otorhinolaryngol. 2009, 73(7):929-931.
11. Robbins J.R., McGuire P.G., Wehrle-Haller B., Rogers S.L. Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. Dev. Biol. 1999, 212(2):255-263.
12. Rotzer D., Roth M., Lutz M., Lindemann D., Sebald W., Knaus P. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B: an alternatively spliced TGF-beta type II receptor. EMBO J. 2001, 20(3):480-490.
13. Iwata J., Parada C., Chai Y. The mechanism of TGF-β signaling during palate development. Oral Dis. 2011, 17(8):733-744.
14. Massague J., Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett. 2012, 586(14):1953-1958.
15. Kohama K., Nonaka K., Hosokawa R., Shum L., Ohishi M. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J. Dent. Res. 2002, 81(10):688-694.
16. Huang X., Yokota T., Iwata J., Chai Y. Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis. J. Dent. Res. 2011, 90(8):981-987.
17. Bertolino P., Deckers M., Lebrin F., ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005, 128(Suppl. 6):585S-590S.
18. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997, 8(1):21-43.
19. Iordanskaia T., Nawshad A. Mechanisms of transforming growth factor β induced cell cycle arrest in palate development. J. Cell Physiol. 2011, 226(5):1415-1424.
20. Zhu X., Ozturk F., Liu C., Oakley G.G., Nawshad A. Transforming growth factor-β activates c-Myc to promote palatal growth. J. Cell. Biochem. 2012, 113(10):3069-3085.
21. Zhu X., Ozturk F., Pandey S., Guda C.B., Nawshad A. Implications of TGFβ on transcriptome and cellular biofunctions of palatal mesenchyme. Front. Physiol. 2012, 3:85.
22. He F., Xiong W., Wang Y. Epithelial Wnt/β-catenin signaling regulates palatal shelf fusion through regulation of Tgfβ3 expression. Dev. Biol. 2011, 350(2):511-519.
23. Blavier L., Lazaryev A., Groffen J., Heisterkamp N., DeClerck Y.A., Kaartinen V. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol. Biol. Cell 2001, 12(5):1457-1466.
24. Venza I., Visalli M., Parrillo L., De Felice M., Teti D., Venza M. MSX1 and TGF-beta3 are novel target genes functionally regulated by FOXE1. Hum. Mol. Genet. 2011, 20(5):1016-1025.
25. Yao Z., Chen D., Wang A., Ding X., Liu Z., Ling L., et al. Folic acid rescue of ATRA-induced cleft palate by restoring the TGF-β signal and inhibiting apoptosis. J. Oral Pathol. Med. 2011, 40(5):433-439.
26. Sun D., Vanderburg C.R., Odierna G.S., Hay E.D. TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development 1998, 125(1):95-105.
27. Ahmed S., Liu C.C., Nawshad A. Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3. Dev. Biol. 2007, 309(2):193-207.
28. Van Der Put N.M., Steegers-Theunissen R.P., Frosst P., Trijbels F.J., Eskes T.K., Van Den Heuvel L.P., et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995, 346(8982):1070-1071.
29. Prescott N.J., Winter R.M., Malcolm S. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J. Med. Genet. 2002, 39(5):368-369.
30. Van Rooij I.A., Vermeij-Keers C., Kluijtmans L.A., Kluijtmans M.C., Ocké M.C., Zielhuis G.A., et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate?. Am. J. Epidemiol. 2003, 157(7):583-591.
31. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 1995, 11(4):409-414.
32. Vieira A.R., Orioli I.M., Castilla E.E., Cooper M.E., Marazita M.L., Murray J.C. MSX1 and TGFB3 contribute to clefting in South America. J. Dent. Res. 2003, 82(4):289-292.
33. Lidral A.C., Romotti P.A., Basart A.M., Doetschman T., Leysens N.J., Daack-Hirsch S., et al. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am. J. Hum. Genet. 1988, 63(2):557-568.
34. Reutter H., Birnbaum S., Mende M., Lauster C., Schmidt G., Henschke H., et al. TGFB3 displays parent-of-origin effects among central Europeans with nonsyndromic cleft lip and palate. J. Hum. Genet. 2008, 53:656-661.
35. Suazo J., Santos J.L., Scapoli L., Jara L., Blanco R. Association between TGFB3 and nonsyndromic cleft lip with or without cleft palate in a Chilean population. Cleft Palate Craniofac. J. 2010, 47:513-517.
36. Zhu J., Hao L., Li S., Bailey L.B., Tian Y., Li Z. MTHFR, TGFB3, and TGFA polymorphisms and their association with the risk of non-syndromic cleft lip and cleft palate in China. Am. J. Med. Genet. 2010, 152A(2):291-298.
37. Kim M.H., Kim H.J., Choi J.Y., Nahm D.S. Transforming growth factor-beta3 gene SfaN1 polymorphism in Korean nonsyndromic cleft lip and palate patients. J. Biochem. Mol. Biol. 2003, 36:533-537.
38. Betsholtz C., Karlsson L., Lindahl P. Developmental roles of platelet-derived growth factors. Bioessays 2001, 23:494-507.
39. Choi S.J., Marazita M.L., Hart P.S., Sulima P.P., Field L.L., McHenry T.G., et al. The PDGF-C regulatory region SNP rs28999109 decreases promoter transcriptional activity and is associated with CL/P. Eur. J. Hum. Genet. 2009, 17(6):774-784.
40. Ding H., Wu X., Bostrom H., Him I., Wong N., Tsoi B., et al. A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat. Genet. 2004, 36:1111-1116.
41. Han J., Xiao Y., Lin J., Li Y. PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells. Birth Defects Res. 2006, 77:438-444.
42. Han J., Li L., Zhang Z., Xiao Y., Lin J., Zheng L., et al. Platelet-derived growth factor C plays a role in the bronchial arch malformations induced by retinoic acid. Birth Defects Res. A: Clin. Mol. Teratol. 2007, 79:221-230.
43. Liu L., Korzh V., Balasubramaniyan N.V., Ekker M., Ge R. Platelet-derived growth factor A (PDGF-A) expression during zebrafish embryonic development. Dev. Genes Evol. 2002, 212:298-301.
44. Schmahl J., Raymond C.S., Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat. Genet. 2007, 39:52-60.
45. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997, 124:2691-2700.
46. Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., Hofstrand P.D., et al. Platelet-derived growth factor C (PDGF-C): a novel growth factor that binds to PDGF alpha and beta receptor. J. Biol. Chem. 2001, 276(29):27406-27414.
47. Reigstad L.J., Sande H.M., Fluge O., Bruland O., Muga A., Varhaug J.E., et al. Platelet-derived growth factor (PDGF)-C: a PDGF family member with a vascular endothelial growth factor-like structure. J. Biol. Chem. 2003, 278(19):17114-17120.
48. Jinnin M., Ihn H., Mimura Y., Asano Y., Yamane K., Tamaki K. Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts. J. Cell Physiol. 2005, 202:510-517.
49. Reigstad L.J., Martinez A., Varhaug J.E., Lillehaug J.R. Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines. Exp. Cell Res. 2006, 312(6):782-795.
50. Alkuraya F.S., Saadi I., Lund J.J., Turbe-Doan A., Morton C.C., Maas R.L. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 2006, 313(5794):1751.
51. Pauws E., Stanier P. FGF signalling and SUMO modification: new players in the aetiology of cleft lip and/or palate. Trends Genet. 2007, 23(12):631-640.
52. Tallquist M.D., Soriano P. Cell autonomous requirement for PDGFRalpha in populations of cranial and cardiac neural crest cells. Development 2003, 130(3):507-518.
53. Xu X., Bringas P.J.R., Soriano P., Chai Y. PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis. Dev. Dyn. 2005, 232(1):75-84.
54. Rattanasopha S., Tongkobpetch S., Srichomthong C., Siriwan P., Suphapeetiporn K., Shotelersuk V. PDGFRa mutations in humans with isolated cleft palate. Eur. J. Hum. Genet. 2012, 20(10):1058-1062.
55. Joosten P.H., Toepoel M., Mariman E.C., Van Zoelen E.J. Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects. Nat. Genet. 2001, 27(2):215-217.
56. Xie J., Aszterbaum M., Zhang X., Bonifas J.M., Zachary C., Epstein E., et al. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(16):9255-9259.
57. Bachler M., Neubuser A. Expression of members of the Fgf family and their receptors during midfacial development. Mech. Dev. 2001, 100:313-316.
58. Nie X., Luukko K., Kettunen P. FGF signalling in craniofacial development and developmental disorders. Oral Dis. 2006, 12:102-111.
59. Stanier P., Pauws E. Development of the lip and palate: FGF signalling. Front. Oral Biol. 2012, 16:71-80.
60. Riley B.M., Mansilla M.A., Ma J., Daack-Hirsch S., Maher B.S., Raffesperger L.M., et al. Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(11):4512-4517.
61. Riley B.M., Murray J.C. Sequence evaluation of FGF and FGFR gene conserved non-coding elements in non-syndromic cleft lip and palate cases. Am. J. Med. Genet. 2007, 143A:3228-3234.
62. Osoegawa K., Vessere G.M., Utami K.H., Mansilla M.A., Johnson M.K., Riley B.M., et al. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J. Med. Genet. 2008, 45(2):81-86.
63. Patyna S., Haznedar J., Morris D., Freshwater K., Peng G., Sukbuntherng J., et al. Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits. Birth Defects Res. B: Dev. Reprod. Toxicol. 2009, 86(3):204-213.
64. Yagi H., Furutani Y., Hamada H., T.Sasaki T., Asakawa S., Minoshima S., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362(9393):1366-1373.
65. Stalmans I. VEGF: A modifier of the del22q11 (DiGeorge) syndrome?. Nat. Med. 2003, 9(2):173-182.
66. Letra A., Silva R.M., Motta L.G., Blanton S.H., Hecht J.T., Granjeirol J.M., et al. Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts. Birth Defects Res. A: Clin. Mol. Teratol. 2012, 94(7):540-548.
67. Lidral A.C., Romotti P.A., Basart A.M., Doetschman T., Leysens N.J., Daack-Hirsch S., et al. MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1. Arch. Oral Biol. 2007, 52(10):954-960.
68. Letra A., Da Silva R.A., Menezes R., De Souza A.P., De Almeida A.L., Sogayar M.C., et al. Studies with MMP9 gene promoter polymorphism and nonsyndromic cleft lip and palate. Am. J. Med. Genet. A 2007, 143(1):89-91.
69. Nikopensius T., Kempa I., Ambrozaityte L., JagomÔagi T., Saag M., Prane I., et al. Variation in FGF1, FOXE1, and TIMP2 genes is associated with nonsyndromic cleft lip with or without cleft palate. Birth Defects Res. A: Clin. Mol. Teratol. 2011, 91(4):218-225.